Safety and Efficacy of Gliflozin Group Among Patients with Type 2 Diabetes Including Patient's Satisfaction in Saudi Arabia

Al Hejji R, Al Ghamdi M, Al Haqbani D, Al Anazi B, Al Bajjal S, Al Ghadeer A, Al Najjar A and Al Suwaidan S
Additional contact information
Al Ghadeer A: College of Pharmacy, Riyadh, KSA
Al Najjar A: B Pharm, MsFS TQM, Drug & Poison Information Supervisor, SFH, Riyadh, KSA
Al Suwaidan S: Research Consultant, Health Sciences Research Center, PNU, Riyadh, KSA

Biomedical Journal of Scientific & Technical Research, 2019, vol. 18, issue 4, 13708-13714

Abstract: Sodium-Glucose Co-transporter 2 (SGLT2) inhibitors is the newest class of oral hypoglycemic agents that was approved for the management of patients with T2DM...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; SGLT2 inhibitors; T2DM; Fasting; Thirst; Tolerance (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003173.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003173.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:18:y:2019:i:4:p:13708-13714

DOI: 10.26717/BJSTR.2019.18.003173

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().